
Novel E-Selectin антагонист, disrupting клетка survival pathway activation, enhancing chemotherapy response and protecting from toxicity such as mucositis with improved survival in vivo
Novel E-Selectin antagonist, disrupting cell survival pathway activation, enhancing chemotherapy response and protecting from toxicity such as mucositis with improved survival in vivo
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.